Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Clinical trial NCT04738630 · UNKNOWN
Trial details
- NCT number
- NCT04738630
- Sponsor
- Taizhou Hanzhong biomedical co. LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2022-12-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.